Keywords: Eli Lilly, Avid Radiopharma, Alzheimer's diagnostics, Florbetapir

Eli Lilly to acquire Avid Radiopharma - and Alzheimer’s diagnostic - for up to $800 million

Article | 09 November 2010

Print This

US drug major Eli Lilly (NYSE: LLY), which is facing a number of patent loses in the near future and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in